Finance

Lists
PTHS:NYSEAMERICAN
Pelthos Therapeutics Inc
$21.01
-1.18%
(-0.25) 1D
Sep 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTHS...
Open
$21.26
High
$21.68
Low
$21.01
Mkt. cap
80.44M
Avg. vol.
41.30K
Volume
5.45K
52-wk high
$37.50
52-wk low
$18.19
EPS
-$21.82
Shares outstanding
3.83M
No. of employees
92
Open
$21.26
High
$21.68
Low
$21.01
Mkt. cap
80.44M
Avg. vol.
41.30K
Volume
5.45K
52-wk high
$37.50
52-wk low
$18.19
EPS
-$21.82
Shares outstanding
3.83M
No. of employees
92
About Pelthos Therapeutics Inc
CEO-
Employees92
Founded2002
Headquarters-
SectorBiotechnology
Websitepelthos.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.41M
9.39M
10.91M
15.60M
Cost of goods sold
2.46M
2.05M
1.86M
4.21M
Cost of revenue
2.46M
2.05M
1.86M
4.21M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.63M
18.47M
21.10M
26.17M
Operating expense
20.31M
19.35M
22.14M
27.22M
Total operating expenses
22.77M
21.39M
23.99M
31.43M
Operating income
-15.36M
-12.00M
-13.09M
-15.82M
Other non operating income
-
-14.98M
-9.63M
-3.70M
EBT including unusual items
-16.70M
-28.59M
-25.07M
-23.42M
EBT excluding unusual items
-16.70M
-28.30M
-25.07M
-21.92M
Income tax expense
-465.00K
-6.92M
-
-
Effective tax rate
2.78%
24.21%
-
-
Other operating expenses
-
-
-
-
Net income
-16.24M
-21.66M
-25.07M
-23.42M
Net profit margin
-219.25%
-230.74%
-229.90%
-150.08%
Earnings per share
-5.30
-2.69
-4.66
-3.79
Interest and investment income
5.00K
-
-
-
Interest expense
-1.35M
-1.31M
-2.35M
-2.39M
Net interest expenses
-1.34M
-1.31M
-2.35M
-2.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.01M
-10.79M
-11.59M
-14.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps